News and recent announcements
News about Croda, our innovative ingredients, sustainability achievements and collaborations with customers, academia and innovation partners.
Find out more about Croda
News
Read our diverse range of articles, press releases, and announcements that reflect our dedication to excellence, sustainability, and growth.
For enquiries regarding our media content, please visit our Contact media enquiries page for more details.
For enquiries regarding our media content, please visit our Contact media enquiries page for more details.
Image library
View and download a range of our high-resolution images to accompany articles and information about Croda
Our latest stories
.jpg?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=94BF97893ABA3C826F742440D8178A3D)
New Croda Beauty product: Zenakine™
8 September 2025: Croda International Plc (“Croda”), the company that uses smart science to create high-performance ingredients and solutions that improve lives, has recently launched Zenakine™, a biotech-based neuroactive ingredient designed to counteract the effects of stress on the skin.
Half year results announcement 2025
Croda International Plc the company that uses smart science to create high-performance ingredients and solutions that improve lives, announces its results for the six months ended 30 June 2025.
Croda’s first product launch specifically focusing on the biopesticide market
28 September 2023: Croda has launched the new product Atlox™ BS-50, a delivery system which specifically meets the needs of the growing biopesticide market.
Appointment of Chair Designate
22 September 2023: We are pleased to announce the appointment of Danuta Gray as a Non-Executive Director and Chair Designate
Croda introduces new bioprocessing solutions to replace banned materials
30 August 2023: Croda has introduced a range of new bioprocessing aids called Virodex™.
Half year 2023 results
Continued investment and strategic progress despite a challenging environment.
Croda successfully completes acquisition of Solus Biotech
4 July 2023: Croda International Plc (‘Croda’) today confirms completion of Solus Biotech acquisition.
Croda announces Global Technical Centre in Hyderabad
5 June 2023: Croda is investing in the new 23,680 square-foot facility to manufacture ingredients for drug delivery systems used in novel therapeutic drugs.
Croda breaks ground on new manufacturing facility for pharmaceutical excipients
5 June 2023: Croda is investing in the new 23,680 square-foot facility to manufacture ingredients for drug delivery systems used in novel therapeutic drugs.
Croda joins forces with academic experts to develop sustainable polymers for a clean future
Croda International Plc and the Universities of Nottingham and York have today announced a collaborative partnership to develop novel, sustainable polymers for liquid formulations.
Two new partnerships for the pharmaceutical industry
Croda announces two new partnerships to drive sustainable delivery systems for the pharmaceutical industry
Appointment of Non-Executive Director
24 March 2023: We are pleased to announce the appointment of Non-Executive Director, Chris Good
11th Most Sustainable International Company
We are celebrating being ranked the top of the chemicals sector for the sixth year running in Britain’s Most Admired Companies award
Full year 2022 results
Powerful operating model and consistent execution delivers record performance.
Jez Maiden to retire as Croda Group Finance Director; Louisa Burdett appointed as successor
7 November 2022: Jez Maiden, Group Finance Director, will be retiring from the Company during 2023 after eight years in the role, Louisa Burdett has been appointed to succeed Jez.
Croda joins the World Business Council for Sustainable Development
Croda International Plc, the company that uses smart science to create high-performance ingredients and solutions that improve lives, has today joined over 200 of the world’s leading sustainable...
Launch of first report on biotechnology opportunities in the personal care market
27 September 2022: The “Biotechnology: personal care market report” is the first in a series from Croda which aim to help other forward-thinking companies leverage the opportunities offered by...
Excellent first half performance driving profit growth
Excellent first half performance driving profit growth
U.S. Government to support expansion of Croda lipid systems capability
Today we announce a joint investment with the U.S. government to expand our U.S manufacturing capacity for lipid systems used in novel therapeutic drugs, such as mRNA vaccines
Croda at a glance
At Croda, we are driven by our Purpose, to use smart science to create high-performance ingredients and technologies that improve lives.
Sustainability
Sustainability spans every area of our business and is a crucial way we add value to our customers.
Innovation
Through our product portfolio we have access to the broadest range of formulation ingredients and formulation know-how, which allows our customers to get the best performance out of their products.